Market Place
Sourcing Support
FDA approvals rise 49% in 2023; CRISPR’s gene editing therapy sees light of day
In 2022, when the
US Food and Drug Administration (FDA) was reeling under the impact of the
pandem
Endocrinology Newsmakers: Drugmakers work on triple agonist treatments, gene therapies to fight diabetes
Endocrinology, a medicinal
branch that deals with endocrine and metabolic disorders, is witnessing
